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ABSTRACT 
 
 
 
 The goal of this project was to test Pichinde virus isolates for in vitro and in vivo 
viability, and to determine the best candidate for a new progenitor stock.  This determination was 
made through plaque assays for the in vitro study, and through ICCS FACS analysis for the in 
vivo study.  The results indicate that the #11 72h Pichinde isolate was the best candidate because 
it grew consistently to a high titer in vitro and produced the most pronounced immune response 
in vivo. 
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BACKGROUND 
 
 
Arenavirus History 
 Arenaviridae receive their name from the Latin root Arena, meaning sand, due to the 
grainy appearance of ribosomes seen in virion cross-sections (Rowe et al, 1970) (Figure-1). 
These viruses are known to cause chronic infections in rodents worldwide, and often establish 
persistent infections during which asymptomatic animals carry and shed virus. Persistently 
infected rodents serve as a reservoir of virus which may be spread to humans upon contact with 
infected materials. Human arenavirus infections are fairly common and may be severe. 
Moreover, transplant patients receiving organs from donors infected with a common arenavirus, 
LCMV, have experienced significant morbidity and mortality (Lymphocytic…2005).  The 
mechanisms by which Arenaviridae persist in rodents are complex, and their study has 
contributed significantly to a better understanding of immunology. 
 
  
 
 
 
 
 
 
 
Figure 1: Electron Microscopy of Arenaviruses.  (Field’s Virology, 2006). 
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 While studying the 1933 St. Louis encephalitis epidemic, Lillie and Armstrong were the 
first to isolate an arenavirus (Armstrong and Lillie, 1934). This virus, lymphocytic 
choriomeningitis virus (LCMV), was subsequently identified in 1935 to be the cause of human 
meningitis (Rivers and Scott, 1935).  After this initial discovery, many other studies were 
conducted that determined LCMV to be a common human pathogen. Over the next forty years, 
other viral isolates from chronically infected rodent hosts, such as Machupo and Tacaribe were 
discovered to share similar morphology (Murphy et al., 1969) and serology with LCMV (Rowe 
et al., 1970).  For those reasons, the viruses were grouped together into the Arenaviridae family.  
Currently, new arenaviruses are discovered approximately every one to three years. Though 
extremely similar morphologically, some of the arenaviruses cause severe symptoms in humans 
while others do not. 
 
Arenavirus Taxonomy 
 The Arenaviridae family contains only the genus arenavirus, which includes eighteen 
arenavirus species, seven of which are known to be human pathogens, while eleven are not 
(Clegg, 2000). An important distinction made among arenaviruses is between the Old World 
group and the New World group, also referred to as the LCM/Lassa complex and the Tacaribe 
complex, respectively. While serologic assays were used to initially separate Old from New 
World viruses, genetic analysis has since been used to more completely investigate their 
interrelatedness.  Nucleoprotein and glycoprotein genetic sequence analysis has made it easier to 
appropriately classify Arenaviridae (Figure-2). Within the New World arenaviruses, three 
distinct evolutionary lineages emerge. Lineage A includes Flexal, Parana, Pichinde, Pirital, 
Tamiami, and Whitewater Arroyo. Lineage B contains Guanarito, Junin, Machupo, Sabia, 
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Amapari, and Tacaribe. Lineage C is home only to two viruses, Latino and Oliveros. All four of 
the South American arenaviral hemorrhagic fevers are members of the B lineage, and this 
suggests that perhaps this phenotype was passed down by a common pathogenic ancestor.  
 
Figure 2: Arenaviridae Phylogenetic Map. (Field’s Virology, 2006) 
 
 It is interesting to note that two viruses in the B lineage (Junin and Machupo) have rodent 
hosts of the same genus (Calomys), while three viruses in the A lineage (Flexal, Parana, and 
Pichinde) also share a common host genus (Oryzomys). This is evidence for co-evolution 
between the viruses and their host. There is no such longitudinal trend observable among Old 
World arenaviruses, nor are there separate and distinct evolutionary lineages. Indeed, up to a 
25% nucleotide difference in the nucleoprotein gene exists between the Lassa virus strains.  
 
 
 8
Arenavirus Structure 
 Understanding viral structure is crucially important to better understanding viral function 
and regulation. All Arenaviridae are enveloped viruses that contain a segmented linear 
ambisense ssRNA genome. They range in size from 50 to 300 nm while averaging 110-130 nm 
in diameter. Tetrameric complexes of two viral glycoproteins, G1 and G2, project outward from 
the surface of the virion envelope (Burns and Buchmeier, 1991). As such, monoclonal antibodies 
against both have been developed in attempts to neutralize viral activity, though anti-G1 
antibodies are more effective. Three major polypeptides are contained in the viruses, RNA 
transcriptase included. Arenaviruses include two nucleocapsids that are helical in shape. These 
nucleocapids are filamentous and form closed circles.  
 The two single stranded RNA segments that make up an arenavirus genome are referred 
to as the S and L segments, for small and large, respectively (Figure-3). The entire genome is 
approximately 10,000-11,000 nucleotides long, with 7000-7400bp making up the L segment, 
while the S segment is roughly 3400bp long.  For a number of arenaviruses including LCVM, the 
complete genome has been sequenced. As shown by Auperin et al (1982), the nucleotide 
sequence at the 3’ termini of New and Old World arenaviruses is conserved.  This is important 
not only for its evolutionary implications, but also because the 3’ termini of both the S and L 
RNA segments are identical at 17 of their final 19 nucleotides. Unlike many 5’ ends, the 5’ 
terminus in arenaviruses does not contain a cap. Due to the apparent circular nature of  
arenavirus nucleocapsids when viewed under the microscope, it is believed that the 3’ and 5’ 
ends base pair to form panhandle structures.  
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Figure 3: Diagram of the Arenavirus Genome.  Note the existence of 
S and L RNA segments encoding different viral genes.  The arrows 
denote the coding strategy.  Also shown are the non-coding intergenic 
regions (IGR) which form 1-3 stem-loop structures that play an 
important role in viral entry and transcription.  (Field’s Virology, 2006) 
 
  The nucleoprotein and two envelope glycoproteins are both encoded by genes contained 
within the S RNA segment. In 1987, it was shown that GP1 and GP2 are first expressed as a 
precursor protein, GPC, which is then cleaved into two after translation (Buchmeier et al., 1987). 
Included in the L RNA segment are genes that encode the viral polymerase, or L protein, and the 
Z protein whose function remains unknown. The genes are oriented in an ambisense 
arrangement, meaning their genome contains both positive and negative sense. The ssRNA 
ambisense genome of arenaviruses is primarily negative-sense except for a part of the 5’ ends of 
both fragments. The nucleoprotein gene is on the 3’ end of the S RNA segment, while the 
polymerase gene is located at the 3’ end of the L RNA segment. On the 5’ ends of the S and L 
RNA segments reside the GPC and Z protein genes, respectively.  
 Between the two genes contained on each segment is an interesting intergenic region of 
the arenavirus genomic RNA.  It was shown in 1984 that these regions, which are anywhere from 
59-217 nucleotides long, form between one to three stem-loop structures in the genomic and 
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antigenomic sense (Auperin et al., 1984). These structures are non-coding  regions of the 
genomic segments but they play an important role in viral entry and transcription. 
 
Arenaviral Proteins 
 The arenavirus genome encodes four proteins: NP, GPC, Z, and L. The most important 
structural protein in arenavirions is the nucleoprotein (NP), which has a molecular size between 
60-68 kd.  The NP associates with virion RNA in an arrangement of beadlike structures. It is also 
the predominant protein component of their nucleocapsids.  It was shown in 1986 that the NP 
may become phosphorylated following an acute infection, and that this new form becomes 
increasingly prevalent in persistent infections (Bruns et al., 1986). Once a cell has become 
infected, NP has been shown to localize exclusively within the cell cytoplasm. The exception to 
this rule is that Pichinde NP contains a degradation fragment that localizes instead within the 
nucleus of infected cells.  
 The precursor GPC protein, which is cleaved post-translationally into GP1 and GP2, is 
generally between 70-80 kd in size. This cleavage requires prior glycoslyation and must take 
place in the area surrounding the trans-Golgi network. The GP1 protein is cleaved from the 
amino-terminal side of the GPC while the GP2 protein is cleaved near an arginine-arginine motif 
which happens to be conserved in all arenaviruses except for Tacaribe. No GPC proteins remain 
uncleaved and this explains why both glycoproteins are found to exist in virions in equimolar 
amounts. The GP1 and GP2 are by no means particularly similar to one another, however.  GP1 
is the peripheral membrane glycoprotein and it assembles into homotetrameric complexes held 
together through disulfide bonding. These GP1 complexes make up the globular head of 
glycoprotein spikes. GP2, on the other hand, is the integral membrane glycoprotein although it 
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does include a membrane spanning domain. Cross-linking studies have shown that highly 
charged residues at the carboxyl end of GP2 molecules interact with NP in the cytosol. Similar to 
the homotetrameric GP1 compelxes, GP2 molecules form homotetramers and become the stalk 
portion of the glycoprotein spike. The GP1 and GP2 homotetramers bind one another through 
ionic interactions.  
 The L protein is the largest protein by far encoded by the arenavirus genome, with a 
molecular size between 180-250 kd (Lukashevich et al., 1997). The L gene site is responsible for 
encoding the viral polymerase, and the L protein is a component of the nucleocapsid. 
Alternatively, the Z protein is the smallest protein encoded by the arenavirus genome. It has a 
molecular size of 11 kd. As mentioned earlier, the function of the Z protein is not entirely clear, 
however it is believed to be a structural protein that is also a component of the nucleocapsid. 
Unlike NP which specifically localizes to the cytoplasm, Z protein has been shown to appear in 
the cytoplasm and the nucleus of LCMV-infected cells.  
 
Arenaviral Entry and Pathology 
 The viral infectious cycle begins with entry of the virus particle into a permissive host 
cell. To accomplish this, arenaviruses use the GP1 part of the glycoprotein spike for initial 
binding to cell surface receptors. For this reason, anti-GP1 antibodies are effective against 
blocking viral infection.  GP1 binds cellular glycoprotein alpha-dystroglycan, discovered in 1998 
(Cao et al., 1998). Guanarito is an arenavirus that does not bind to alpha-dystroglycan, so it is 
clear that other cellular proteins may serve as arenavirus receptors. Once the arenavirus has 
attached to the cellular protein receptors, they enter the cell by way of a large endocytic vesicle. 
In 1994, the mechanism of LCMV entry into cells was published explaining how viral 
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nucleocapsids are delivered into host cells by pH-dependent fusion between the virion and 
endosomal membranes (Di Simone and Buchmeier, 1995).  It is pH-dependent because the GP1 
and GP2 dissociate at an acidic pH, and this triggers fusion activity.  
 After the nucleocapsids enter the cytoplasm, viral replication is initiated by the L protein 
(the viral polymerase) in a transcription method that resembles bunyaviruses (Figure-4). It is 
possible to reduce viral replication by treatment with actinomycin D, which acts to make the L 
protein less effective.  The two RNA strands have common 3’ end sequences complementary to 
their respective 5’ ends.  Occasionally, portions of the RNA will fold into stem-loop structures, 
and it is thought that these formations in the intergenic region have something to do with 
transcriptional termination by stabilizing the 3’ ends.  Nucleoprotein mRNA can sometimes be 
seen as early as two hours post-infection, while the NP itself makes its appearance sometime 
between 6-12 hours. It requires twice this time for any L protein to be detected, but by then the 
virus is present.  
 
Figure 4: Basic Arenavirus Replication and Transcription for the S 
Segment.  (Field’s Virology, 2006) 
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 Despite the amount of research focus directed toward arenaviruses, their precise assembly 
post-infection is not exactly known.  The current assembly model suggests that the NP protein, L 
protein, and genomic RNAs combine to form nucleocapsids. Strangely, arenaviruses then 
arrange host-cell ribosomes into virion particles. Assuming uninhibited entry, virus assembly 
will proceed as a result of membrane budding, and arenaviruses are capable of easily establishing 
a persistent infection in rodent cells.  
  
Persistent Infection and Defective Interfering Particles 
 A persistent infection is one in which the virus is not cleared from the host, but instead 
remains present in some specific cells. There are three types of persistent infection: latent, 
chronic, and slow.  Arenavirus infections are capable of producing persistent infections in their 
hosts, as well as in vitro through a series of changes in viral gene expression. In cell culture, 
arenavirus infections transition from an acute phase into a persistent phase. Virus is actively 
being produced and replicated during the acute phase, and once this slows significantly, the virus 
may enter the persistent phase characterized by life-long infection.  It was shown that over the 
time of a persistent LCMV infection, the relative amount of S RNAs becomes greater than the L 
RNAs (Francis and Southern, 1988).  When an L cell is persistently infected, a greatly increased 
amount of NP is seen, while GPC, GP1, and GP2 are reduced.  
 A defective interfering (DI) particle is a virus without part of its genome. As a result of 
missing this information, DI particles or their expressed RNAs are incapable of sustaining a 
persistent infection by themselves, and instead require the assistance of a helper virus for co-
infection. With arenaviruses, DI particles are produced during acute and persistent infections, 
and they interfere with viral infectivity.  DI particles are actually smaller than normal infectious 
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virions and have a mean diameter of 55-56 nm. Among other differences from the norm, DI 
particles can be missing either GP1 or GP2, or they can be nonglycosylated.  Additionally, the 
NP and GPC are abnormally sized.  Interestingly, a DNA form of the LCMV S RNA has been 
found in the spleens of persistently infected mice (Klenerman et al., 1997). 
  
The Welsh Lab at UMASS Medical School 
 Dr. Raymond Welsh’s research pathology laboratory at UMASS Medical School 
(Worcester) is principally concerned with analyzing mechanisms of viral immunology and 
immunopathlogy. This is done through the use of mouse infection models using several viruses 
including vaccinia virus, herpes simplex virus, and mouse hepatitis virus. Arenaviruses such as 
LCMV and Pichinde are also used in the lab, among others. The Welsh lab is BSL-2 and infected 
mice are maintained in a BSL-2 facility. His lab showed that natural killer cells are activated 
during a viral infection, and are an important part of viral resistance. Taking this further, the lab 
is now determining exactly which viral gene products are important to NK sensitivity for a 
variety of viruses, and what NK functions relate to antiviral activity.  Additionally, they are 
looking at virus-specific cytotoxic T lymphocytes induced during viral infections to examine 
factors that affect CTL memory, development, and maintenance. 
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PROJECT PURPOSE 
 
 
 As stated in the Background, the Welsh lab at UMASS Medical analyzes the mechanisms 
of viral immunology and immunopathlogy through mouse model infections. One of the viruses 
analyzed is Pichinde virus (PV), an arenavirus.  Recently, it became apparent that their PV 
experiments were not validating similar experiments conducted previously, posing a serious 
problem especially for longitudinal studies.  It was determined that their PV progenitor stock was 
growing to a significantly smaller titer than their previous stock, and that this was the cause of 
the experimental discrepancies. The purpose of this project was to select, grow, and functionally 
analyze three alternative PV isolates to determine the best candidate for a new progenitor stock.  
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METHODS 
 
 
Cell Lines and Media 
 Three different cell lines were used in this investigation. Vero cells are kidney epithelial 
cells derived from African green monkeys. Vero cells are frequently used as host cells for 
growing viruses. The cells were maintained and passed primarily in T25 flasks containing 
Minimum Essential Medium (MEM), 500 ml of which was supplemented with  50 mL of fetal 
calf serum (to 10%), 5 mL L-glutamine, 5 mL PenStrep, and 5 mL Hepes.  
 BHK cells are baby hamster kidney cells.  BHK cells are fibroblastic and are generally 
used as a viral host. The cells were maintained and passed primarily in T25 flasks containing 
Dulbecco's Modified Eagle Media (DMEM), 500 ml of which was supplemented with 50 mL 
fetal calf serum (to 10%), 10 mL L-glutamine, and 5 mL PenStrep. 
 NCTC-929 cells are mouse immortalized liver fibroblasts. The purpose of the NCTC-929 
cells was to repeat experiments previously conducted in BHK cells to determine that analogous 
results would be obtained using mouse cells. The cells were maintained and passed primarily in 
T25 flasks containing Minimum Essential Medium (MEM), 500 ml of which was supplemented 
with 50 mL fetal calf serum (to 10%), 5 mL L-glutamine, 5 mL PenStrep, and 5 mL Hepes. 
 Eagle's Minimal Essential Medium (EMEM) was used in the plaque assays. It was mixed 
with a recipe of 10 mL fetal calf serum, 2 mL L-glutamine, and 2 mL PenStrep.  
 
Virus 
 The Welsh lab progenitor stock for Pichinde virus lost its homogeneity over time due to 
its being prone to accumulating point mutations. This resulted in several emergent quasi-species. 
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This progenitor stock was plaqued and these quasi-species were isolated based on plaque 
morphology. Three of these Pichinde virus isolates (#1, #6, and #11) were selected based on 
differences in morphology for new progenitor stock candidate analysis. BHKs were grown in 
DMEM and incubated for 3 days to 70-80% confluency.  A cell count was taken and total cells 
was determined.  The following equation was used to determine how much virus should be 
added to one T150 of BHKs: total # of cells in the flask x multiplicity of infection of 0.01 / 
pfu/mL. Once the correct amount of virus was added for each of the three isolates, the flasks 
were mixed every 30 minutes for 90 minutes. After 24 hours, the T150s containing PV isolates 1, 
6, or 11 had 50 mL supernatant (containing virus) taken up into separate conical tubes which 
were spun down for five minutes. From each isolate, seven vials were filled with 4 mL, and three 
additional aliquots were filled with 100 µL. These aliquots were frozen at -80C. This aliquotting 
process was repeated at 48 hours and once more at 72 hours. At this point, seven 4mL vials and 
three 100 µL aliquots were frozen for each of the three stocks at each of three time points. 
  
Plaque Assay 
 Once virus samples were taken of each of the three stocks at three time points, a plaque 
assay was conducted to determine their viral titers.  In order to plate the cells into 6-well plates 
for the plaque assay, a cell count was done. 2.5x105 cells per well were prepared in 2mL of 
media.  
 In a 96-well plate, wells in the first column were filled with 200 µL of each of the nine 
recently frozen viral samples (e.g. #1 at 24 hours, #6 at 72 hours, etc.). A positive control was 
included in the final row. The remaining wells were filled with 180 µL of DMEM.  The virus 
samples that were loaded in the first column were then serially diluted left to right across the 
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plate with 20 µL being taken from the first well, added to the second, mixed, and so on. The final 
six dilutions were added to appropriately labeled 6-well plates. The plates were tilted every 30 
minutes for 90 minutes so that the virus would evenly distribute across the cells. After 90 
minutes incubation, the plates were overlayed with a 50/50 mixture of EMEM and agarose. 4mL 
of this mixture was added to each well. The purpose of this overlay is to fix the viral plaques in 
place such that each plaque formation will be independent.  
 After 3 days incubation, the wells were stained so that the plaques would be visible and 
quantifiable. This staining was done by the addition of 2 mL/well of a 50/50 mixture of 
EMEM/agarose and 150 µL of neutral red per 10 mL total volume. This second overlay was 
allowed to incubate overnight, and the plaques were counted the next day. 
 
Intracellular Staining 
 IFN-gamma producing CD8 T cells were detected using the Cytofix/Cytoperm Kit Plus 
(with GolgiPlug; BD PharMingen). Splenocytes (2x106 cells per culture well) were incubated 
with 5 µM synthetic peptide in the presence of 10 U/ml human recombinant IL-2 (BD 
Pharmingen) and 1 µl/ml GolgiPlug for 5 hours at 37C.  Following the incubation, splenocytes 
were stained for cell surface markers. The samples were washed once using Staining Buffer 
(PBS without Mg2+ or Ca2+; 1% FCS, 0.09% Sodium Azide) with 200 µl/well, and centrifuged 
for 5 minutes at 1200 rpm. FC receptors were blocked using 2.4G2 antibody for 5 minutes at 4°C 
in 100 µl of staining buffer. 100 µl of staining buffer was added in another wash, which was 
centrifuged for 5 minutes at 1200 rpm. The cells were stained for surface antigens using 
appropriate antibodies in 100 µl of staining buffer for 20 minutes at 4°C. Cells were washed 
twice with staining buffer. Samples were then fixed and permeabilized with Cytofix/Cytoperm 
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solution for 20 minutes at 4C. Cells were washed twice in 1X Perm/Wash solution (dilute 10X 
stock in dH2O). They were then resuspended in 100 µl of Perm/Wash solution containing anti 
IFN-gamma (clone XMG1.2; BD Pharmingen). The samples were incubated for 25 minutes at 
4°C, washed twice with 1X Perm/Wash, washed with staining buffer, and put into a final volume 
of 300µl staining buffer for analysis. The samples were analyzed using a BD LSR II Analyzer 
(BD Biosciences) and CellQuest Software (BD Biosciences).   
 
Tetramer FACS Staining 
 Splenocytes (2x106) were added per well for staining followed by the addition of 100 µl 
of FACS buffer to each well. Samples were centrifuged and decanted.  FC block was diluted 
1:100 into FACS buffer, and 100 µl of this was added to each well to block non-specific staining.  
Cells were incubated for 5 minutes at 4°C, and then centrifuged for five minutes and decanted. 
100 µl of FACS buffer was added, and then cells were costained with indicated peptide-loaded 
tetramer and anti-CD8 clone, after which cells were incubated for 45 minues at 4°C.  After 
washing twice with FACS buffer, samples were stained for intracellular IFN-gamma as 
described above. 
 
Mice and In Vivo Infections 
 C57BL/6 mice were purchased from Jackson Laboratories (Bar Harbor, ME) at 5-6 
weeks of age. Mice were infected with 107 pfu of PV through IP injection. After 3 days, spleens 
and fatty pads were harvested and manually ground with a drill press. A plaque assay, as 
described previously, was conducted on the spleens and fatty pads in order to determine viral 
load. After 8 days, spleens were harvested and intracellular stain and tetramer stain protocols 
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were conducted as described previously. All experiments were done in compliance with 
institutional guidelines as approved by the Institutional Animal Care and Use Committee of the 
University of Massachusetts Medical School (Worcester, MA).  
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RESULTS 
 
 
 
 The goal of this project was to investigate the viability and functionality of several 
Pichinde virus isolates (#1, #6, #11) previously prepared in our laboratory to determine the best 
potential candidate for developing a new progenitor stock.  The current lab stocks had proven 
unreliable relative to earlier lab experiments, and it would be imprudent to proceed with rodent 
infections without first proving that the viruses were viable and can replicate in a host organism. 
In order to accomplish this, viral growth was measured and compared in vitro and in vivo.  
 
In Vitro Plaque Assays 
 The three previously prepared Pichinde isolates were freshly grown in BHK cell culture 
and harvested at 24h, and 48h time points. These harvested aliquots were serially diluted in 6 
well plates, and the 106 dilutions of each were added onto a single 6-well plate.  After mixing 
with agarose, the plates were incubated overnight, then stained and the plaques were counted 
(Table I).  Sample #1 taken at 24 hrs produced the highest titer of virus, and the rest of the 
samples were approximately equal and slightly lower.  However, this was far too little 
information to make a determination that #1 was the best stock candidate, as it dropped 
significantly in titer between samples taken at 24h and 48h. The main purpose for this plaque 
assay was to observe relative plaque morphology. The #11 plaques were the most consistently 
clear and evenly sized while the #6 plaques were rather varied and fuzzy. The #1 isolate 
produced a mixture of sharp and fuzzy plaques without much size variation. 
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Table I.  Plaque Assay Count for Pichinde Viral Isolates 
PV #1, 6, 11 at 24h and 48h Plated on Vero Cells 
Sample 
Incubation 
Time 
Number 
of 
Plaques 
in the 
106 
Dilution Titer 
Control 
  
5 5x106 
1 24 Hr 91 9.1x107 
1 48 Hr 51 5.1x107 
6 24 Hr 52 5.2x107 
6 48 Hr 68 6.8x107 
11 24 Hr 55 5.5x107 
11 48 Hr 41 4.1x107 
 
 
 In order to get a determination of the stock titers, the same time points were plaqued once 
more in vero cells, this time plaques were quantitated at both 106 and 107 dilutions (Table II).  
As before, the 106 dilution saw double digit plaque formation, and stock #1 taken at 24 hrs as the 
highest titer, but the 107 dilution likely better represents the viral titers, and several stocks gave 
titers equivalent to #1 at 24 hr.  Interestingly, the number of plaques are noticeably lower in the 
106 dilution the second time around. This is not cause for concern, however, as the log order is 
the same, and the decrease was uniform which would suggest a possible procedural difference.  
The purpose for this plaque assay was to get working stocks of each viral isolate with a known 
titer.  
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Table II. Plaque Assay Count for Pichinde Viral Isolates 
PV #1, #6, and #11 at 24h and 48h Plated on Vero Cells 
 
Sample 
Incubation 
Time 
Number of 
Plaques 
Titer 
in the 
106 107 
Dilution Dilution 
Control   ND ND ND 
1 24 Hr 33 5 5x107 
1 48 Hr 27 4 4x107 
6 24 Hr 13 1 1x107 
6 48 Hr 21 5 5x107 
11 24 Hr 20 3 3x107 
11 48 Hr 18 5 5x107 
 
 Now that working stocks of each viral isolate had been generated, the next step was to 
characterize their growth kinetics relative to one another.  For this, the 72h time point was 
included in the next plaque assay (Table III).  
Table III. Plaque Assay Count for Pichinde Viral Isolates PV #1, #6, and #11  
at 24h, 48h, and 72h Plated on Vero Cells to Observe Growth Kinetics 
Sample Incubation Time 
Number of Plaques in the 
Titer 
104 
Dilution 
105 
Dilution 
106 
Dilution 
107 
Dilution 
108 
Dilution 
Control  ** 56 7 0 0 7x106 
1 24 Hr ** ** 20 2 0 2x107 
1 48 Hr **** ** 99 24 0 2x108 
1 72 Hr **** ** 33 10 0 1x108 
6 24 Hr ** 29 2 0 0 2x106 
6 48 Hr **** ** 28 0 0 2x107 
6 72 Hr **** **** ** 15 0 1x108 
11 24 Hr **** ** 17 3 0 3x107 
11 48 Hr **** ** 45 7 0 7x107 
11 72 Hr **** ** ** 19 2 2x108 
(****: full lawn, ***: >200 estimated, **: 100-200 estimated) 
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 The addition of the 72h samples in this plaque broadens the scope significantly and 
presents a new standout candidate: #11 72h. This isolate reached the largest maximum titer and 
shows a continuous rate of growth. This sample grew out to 2x108 which was matched only by 
#1 48h. Curiously, #1 24h was not the frontrunner it was once. In addition to quantifying viral 
titer by counting plaques, it is important to note plaque appearance. Across the board, the #11 
plaques were the most consistently uniform. The #1 plaques were fairly uniform, and the #6 
plaques were highly variable and fuzzy.  
 Now that it had been shown that the viral strains were growing considerably well in BHK 
cells and that there were emerging excellent progenitor candidates, the next step was to perform 
the same experiment in mouse cells. It is entirely possible that the isolates could grow well in 
one type of cell and not in another. NCTC-929 cells are mouse immortalized liver fibroblasts. 
Similarly strong growth in the NCTC-929 cells would be enough evidence to initiate in vivo 
experimentation. The three isolates at each of the three time points were added to NCTC-929 
cells (Table IV). In addition, another plaque assay was done simultaneously from isolates added 
to BHK cells to serve as a control.  
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Table IV. Plaque Assay Count for Pichinde Viral Isolates PV #1, #6, and #11 at 24h, 48h, 
and 72h to Compare NCTC-929 Growth to BHK Control. 
   Number of Plaques in the     
   104 Dilution  105 Dilution 106 Dilution 107 Dilution 108 Dilution Titer 
Sample 
Incubation 
Time BHK 
NCTC-
929 BHK 
NCTC-
929 BHK 
NCTC-
929 BHK 
NCTC-
929 BHK 
NCTC-
929 BHK 
NCTC
929 
Control     ***   **   29   2   0   2x107
1 24 Hr 62 3 12 0 0 0 0 0 0 0 1.2x106 3x104
1 48 Hr *** 30 ** 1 72 0 8 0 0 0 8x107 1x105
1 72 Hr *** ** ** 79 82 5 9 1 1 0 1x108 1x107
6 24 Hr * * 15 12 1 0 0 0 0 0 1x106 1.2x10
6 48 Hr *** ** ** 31 42 3 5 0 1 0 1x108 3x106
6 72 Hr *** *** ** 112 61 18 10 2 0 0 1x108 2x107
11 24 Hr ** 52 44 3 5 0 0 0 0 0 5x106 3x105
11 48 Hr *** ** ** 59 23 14 0 0 0 0 2x107 1.4x10
11 72 Hr *** *** ** ** 31 30 4 4 0 0 4x107 4x107
 
 
 It is apparent from the table that each of the Pichinde isolates did indeed grow 
successfully in the NCTC-929 cells. Once again, the standout is #11 72h, this time followed 
closely by the other two 72h samples. It is interesting to note that none of the 24h samples grew 
to high titers in this experiment. Also, the BHK plaques produced a reduced titer across the board 
as compared to the previous BHK plaque so it is important to compare the NCTC-929 growth to 
the BHK growth in this experiment and not to previous BHK growth. With this in mind, this was 
the final positive evidence necessary to greenlight in vivo analysis. 
 
In Vivo Activity of the Viral Stocks 
 In order to determine whether the viral isolates that had been shown to grow well in vitro 
were capable of similar growth in vivo, C57 mice were infected with each isolate and the plaque 
titer determined for the spleens and fat pads.  As described in the Methods, groups of four 
C57BL/6 (age 5-6 weeks) mice were infected with 107 pfu of each PV isolate through IP 
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injection (samples 1-4 infected with PV isolate #1, samples 5-8 infected with #6, samples 9-12 
infected with #11).  After 3 days, four of the six mice infected with each isolate had their spleen 
and fatty pads harvested and manually ground with a drill press. A plaque assay (described 
previously) was conducted on the spleens and fatty pads (Table V) to determine viral load.  
 
Table V. Plaque Assay for Spleens of Infected C57 Mice. 
Viral Load Determination for Pichinde Viral Isolates PV #1, #6, 
and #11 at 24h, 48h, and 72h 3 Days Post-Infection. 
Sample 
Number of Plaques in the  
101 Dilution 102 Dilution 103 Dilution 104 Dilution 105 Dilution 
Spleen Fat Pads Spleen Fat Pads Spleen Fat Pads Spleen Fat Pads Spleen 
Fat 
Pads 
1 0 14 0 3 0 0 0 0 0 0 
2 4 11 8 1 2 0 0 0 0 0 
3 0 22 1 5 0 1 0 0 0 0 
4 0 20 0 4 0 0 0 0 0 0 
5 0 14 0 6 0 1 0 0 0 0 
6 0 31 4 4 0 1 0 0 0 0 
7 0 17 0 3 0 1 0 0 0 0 
8 0 25 1 4 0 1 0 0 0 0 
9 ** **** ** ** 60 25 8 3 0 0 
10 ** **** * *** 12 27 0 1 1 0 
11 ** **** ** *** 49 50 3 6 0 3 
12 ** **** ** *** 30 22 0 3 0 0 
control **** **** *** 54 10      
 
103 
Dilution 
104 
Dilution 
105 
Dilution 
106 
Dilution 
107 
Dilution      
(Samples 1-4 were infected with PV isolate #1, 5-8 infected with #6, 9-12 infected with #11) 
 
 It is clear that the four samples infected with viral isolate #11 (samples 9-12) show 
significantly higher viral titers in vivo in both the spleen and fat pads.  This is further evidence in 
favor of #11 being the best progenitor candidate.  The samples infected with #1 and #6 show 
evidence of virus in the fat pads out to the 103 dilution, but very little virus is seen in the spleens.  
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 It is important to observe plaque morphology and uniformity. Observing plaque 
morphologies is a preliminary way of determining homogeneity of the viral isolate. High 
variance would suggest possible contamination or mutation. Relative plaque size is also related 
to the amount of virus. Hazy or turbid plaques are indicative of lysogenic reproduction and clear 
plaques indicate lytic reproduction. Photographs were taken of  PV isolate #11 (sample 9 
showing the highest viral load) for plaques from spleen (Figure-5) and fat pads (Figure-6).  
 
 
Figure 5: Photograph of the Spleen Plaques Induced by PV Isolate #11, Sample 9. 
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Figure 6: Photograph of the Fat Pad Plaques Induced by PV Isolate  #11, Sample 9. 
  
 In both cases, fairly consistent plaque morphology was observed.  At lower dilutions, there is an 
apparent size disparity between some of the plaques, but they become increasingly more 
consistent at higher dilutions. From this experiment it can be concluded that in spite of infecting 
the mice with the same viral titers (as assayed in vitro), in vivo the #11 PV isolate was found in 
much higher quantities in spleen and fat pads than the other isolates three days following 
infection.  
 FACS analysis was performed on splenocytes to quantify IFNγ-producing CD8 T cells, 
whose levels are a measure of cellular immune activity (Figure-7).  Mice were infected in the 
same manner as described before with equal titers of the three viral isolates. Two mice were 
infected with #1 72h, two were infected with #6 72h, and three were infected with #11 72h (as 
this latter was the isolate of most interest).  In addition, two naïve mice were used as negative 
controls in this experiment. After 8 days, the spleens were harvested and the splenocytes were 
stained for cell surface markers, and analyzed by FACS as described in the Methods.  
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 The naïve mice should not return evidence of an immune response because they were 
never infected with virus. The first two rows show this to be true. The unstimulated column acts 
as another control; there should not be a noticeable response in this column because no peptides 
antibodies were added.  With the exception of the mouse #3 infected with #11 72h, this holds 
true. The anti-CD3 monoclonal antibody was used here because it serves as a polyclonal 
stimulation for T cells. CD3 antigens are part of the T cell receptor complex and, upon 
engagement, will activate the T cell. NP38-45 is a short peptide derived from the Pichinde 
nucleoprotein that is the dominant target for Pichinde-induced T cell responses. Like CD3, NP38 
positive for IFNγ production indicates immune system activity.  NP205-212 is another short 
peptide derived from the Pichinde nucleoprotein. The CD8 T cell response to the NP205 epitope 
is generally very weak. 
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Figure 7:  ICCS FACS Analysis of Mouse Splenocytes.  The Y axis is IFNγ and the X 
axis is CD44.  CD3 antigens were screened as a T-cell activation marker.  NP38 is 
a PV nucleoprotein-derived peptide that plays a dominant role in Pichinde 
infection immune responses.  NP205 is another nucleoprotein-derived peptide that 
is subdominant. 
 
 
 The naïve mice produced no response to the NP38, NP205, or CD3 antibodies. The #1 
isolate produced a noticeable response to NP38 and CD3, although it reaches 11.8% in mouse #1 
and was 21% for mouse #2, despite receiving the same amount of the same virus, such 
differences are not uncommon. The #6 isolate shows a greater immune response in that the 
maximum NP38 is higher (23.7%) and it has a higher average. While the #11 isolate produced 
the largest NP38 percentage of all (25%), its average is decidedly lower. None of the mice 
showed any significant amount of NP205, which was not especially alarming because the CD8 T 
cell response to NP205 is subdominant. The purpose of quantifying the percent of active 
splenocytes is to determine virulence. Considering all three isolates were injected into mice at 
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the same number of plaque forming units, the one to induce the strongest immune response is the 
most virulent.  
 A tetramer stain was conducted with the same goal in mind as the ICCS (Figure-8) to 
quantify the percentage of splenocytes active in the PV immune response. Biotinylated 
streptavidin MHC tetramers were used to quantify the percentage of antigen-specific T cells. The 
tetramer works by fluorescently labeling any T cell that expresses T cell receptors specific to the 
peptide.  Only NP38 and NP205 tetramers were analyzed.  Cells were gated on CD44 as an 
activation marker, and then again on the two tetramers. The percentages of NP38 tetramer 
positive cells are relatively low for each viral isolate, and surprisingly low for the #11 isolate. 
NP205 detection is virtually nonexistent which is not surprising as it usually shows weak 
response. Consistent with the ICCS results, viral isolate #11 underperformed relative to 
expectations based on its high titers in vitro. 
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Figure 8: Tetramer FACS Analysis of Infected Mice. The Y axis for 
the middle and last column is NP38 tetramer and NP205 tetramer, 
respectively. The X axis is CD44 activation marker. 
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DISCUSSION 
  
 Pichinde virus is highly susceptible to point mutations which, when accumulated over 
time, may dramatically alter the homogeneity of a viral stock.  Such a situation occurred to the 
Pichinde progenitor stock in the Welsh lab at UMASS Medical School (Worcester). To initiate 
development of another stock, viral isolates were examined in vitro, and then in vivo in mice for 
growth kinetics, characteristics, and virulence.  
 Initially, the in vitro analysis indicated viral isolate #11 72h as a promising candidate. In 
the BHK plaque assay, it reached the highest titer (2x108) and showed a continuous growth rate. 
In addition to a strong titer, the #11 isolate in general had the most uniform looking plaque 
formations, sharp and similarly sized.  The #1 48h isolate and the #6 72h isolate also grew to 
high titers in BHK cells.  However in vitro titers determined on BHK cells is not always a good 
indicator of potency, as growth in BHK does not necessarily translate to growth in mice. To 
resolve this, another in vitro plaque assay was performed using NCTC-929 mouse liver cells. 
Here, the #11 72h isolate was the best candidate, reaching the highest titer (4x107). What was 
more important with respect to the second round of experiments was it showed the virus could 
grow in mouse cells. 
 Further evidence of the apparent superiority of the #11 isolate was found in vivo. 
Splenocytes and fat pads harvested from C57 mice three days after infection showed that isolate 
#11 produced significantly higher titers than the other two isolates. Indeed, isolates #1 and #6 
were barely detectable in the spleens, while #11 grew to 104 consistently. All evidence using 
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mouse cells or mice thus far had shown that the #11 isolate, particularly #11 72h, was the clear 
choice for creating a new progenitor Pichinde virus stock. 
 The FACS analysis experiments cast some doubts on the obviousness of #11 as the 
choice isolate. Infection with #11 produced the largest measured NP38 response (25%) in the 
ICCS experiment, but the average NP38 response was 15%.  In contrast, the #6 isolate produced 
consistently high NP38 and CD3 responses. It is important to remember, however, that the #6 
isolate had a variable and fuzzy spleen and fat pad plaque morphology, and that #11 is still likely 
the superior isolate. #6 was shown to induce the largest response when stained for NP38 tetramer 
as well. The disparity is not particularly great, though, and it certainly does not definitively show 
either isolate to be better. 
  Major difficulties with the project were rare, but one in particular stands out. In both the 
ICCS and tetramer results, there are no noticeable responses to NP205.  NP205, like NP38, is a 
peptide derived from the viral nucleoprotein that is active in immune response.  It was expected 
that some NP205 antigen would be present in the infected spleen cells, but none was found in 
any of the mice. Although NP205 is subdominant and CD8 T cell response to it is generally very 
weak, the hope was that at least one of the isolates might induce a noticeable response. It is 
possible that the NP205 antibodies used are no longer intact. This is not necessarily the case, 
though, as the weak response was consistent among the viral isolates and the original virus.  
 In the future, another member in the Welsh lab is going to purify the #11 72h isolate. To 
do this, the virus will be added to T150 flasks containing BHK cells and then incubated for four 
days. After incubation, the supernatants from the flasks containing virus will be harvested into 
50mL tubes and centrifuged to clear cellullar debris.  The supernatants will then be layered onto 
20-60% sucrose gradients, and following centrifugation, the purified virus should rest between 
 37
the 20% and 60% sucrose layers. This progenitor stock will be used in future Welsh lab PV 
experiments. 
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